Cargando…

Application of the Quality by Design Concept (QbD) in the Development of Hydrogel-Based Drug Delivery Systems

Hydrogel-based drug delivery systems are of interest to researchers for many reasons, such as biocompatibility, high diversity, and the possibility of administration from different routes. Despite these advantages, there are challenges, such as controlling the drug release rate and their mechanical...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohseni-Motlagh, S. Farid, Dolatabadi, Roshanak, Baniassadi, Majid, Baghani, Mostafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674248/
https://www.ncbi.nlm.nih.gov/pubmed/38006131
http://dx.doi.org/10.3390/polym15224407
_version_ 1785149688255610880
author Mohseni-Motlagh, S. Farid
Dolatabadi, Roshanak
Baniassadi, Majid
Baghani, Mostafa
author_facet Mohseni-Motlagh, S. Farid
Dolatabadi, Roshanak
Baniassadi, Majid
Baghani, Mostafa
author_sort Mohseni-Motlagh, S. Farid
collection PubMed
description Hydrogel-based drug delivery systems are of interest to researchers for many reasons, such as biocompatibility, high diversity, and the possibility of administration from different routes. Despite these advantages, there are challenges, such as controlling the drug release rate and their mechanical properties during the manufacturing of these systems. For this reason, there is a need for the production and development of such drug delivery systems with a scientific strategy. For this reason, the quality by design (QbD) approach is used for the development of drug delivery systems. This approach, by identifying the most effective factors in the manufacturing of pharmaceutical products and controlling them, results in a product with the desired quality with the least number of errors. In this review article, an attempt is made to discuss the application and method of applying this approach in the development of hydrogel-based drug delivery systems. So that for the development and production of these systems, according to the type of drug delivery system, what target characteristics should be considered (QTPP) and what factors, such as material properties (CMA) or process parameters (CPP), should be taken into account to reach the critical quality attributes of the product (CQA).
format Online
Article
Text
id pubmed-10674248
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106742482023-11-14 Application of the Quality by Design Concept (QbD) in the Development of Hydrogel-Based Drug Delivery Systems Mohseni-Motlagh, S. Farid Dolatabadi, Roshanak Baniassadi, Majid Baghani, Mostafa Polymers (Basel) Review Hydrogel-based drug delivery systems are of interest to researchers for many reasons, such as biocompatibility, high diversity, and the possibility of administration from different routes. Despite these advantages, there are challenges, such as controlling the drug release rate and their mechanical properties during the manufacturing of these systems. For this reason, there is a need for the production and development of such drug delivery systems with a scientific strategy. For this reason, the quality by design (QbD) approach is used for the development of drug delivery systems. This approach, by identifying the most effective factors in the manufacturing of pharmaceutical products and controlling them, results in a product with the desired quality with the least number of errors. In this review article, an attempt is made to discuss the application and method of applying this approach in the development of hydrogel-based drug delivery systems. So that for the development and production of these systems, according to the type of drug delivery system, what target characteristics should be considered (QTPP) and what factors, such as material properties (CMA) or process parameters (CPP), should be taken into account to reach the critical quality attributes of the product (CQA). MDPI 2023-11-14 /pmc/articles/PMC10674248/ /pubmed/38006131 http://dx.doi.org/10.3390/polym15224407 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Mohseni-Motlagh, S. Farid
Dolatabadi, Roshanak
Baniassadi, Majid
Baghani, Mostafa
Application of the Quality by Design Concept (QbD) in the Development of Hydrogel-Based Drug Delivery Systems
title Application of the Quality by Design Concept (QbD) in the Development of Hydrogel-Based Drug Delivery Systems
title_full Application of the Quality by Design Concept (QbD) in the Development of Hydrogel-Based Drug Delivery Systems
title_fullStr Application of the Quality by Design Concept (QbD) in the Development of Hydrogel-Based Drug Delivery Systems
title_full_unstemmed Application of the Quality by Design Concept (QbD) in the Development of Hydrogel-Based Drug Delivery Systems
title_short Application of the Quality by Design Concept (QbD) in the Development of Hydrogel-Based Drug Delivery Systems
title_sort application of the quality by design concept (qbd) in the development of hydrogel-based drug delivery systems
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674248/
https://www.ncbi.nlm.nih.gov/pubmed/38006131
http://dx.doi.org/10.3390/polym15224407
work_keys_str_mv AT mohsenimotlaghsfarid applicationofthequalitybydesignconceptqbdinthedevelopmentofhydrogelbaseddrugdeliverysystems
AT dolatabadiroshanak applicationofthequalitybydesignconceptqbdinthedevelopmentofhydrogelbaseddrugdeliverysystems
AT baniassadimajid applicationofthequalitybydesignconceptqbdinthedevelopmentofhydrogelbaseddrugdeliverysystems
AT baghanimostafa applicationofthequalitybydesignconceptqbdinthedevelopmentofhydrogelbaseddrugdeliverysystems